Bio


Janice Man, MD, is currently a Clinical Assistant Professor for the Department of Anesthesia, Perioperative and Pain Medicine at Stanford University and is board-certified in anesthesiology and pediatric anesthesiology. She completed her medical school education at the Yale University School of Medicine, residency training at UCSF, pediatric anesthesia fellowship training at CHOP, and her pediatric regional anesthesia fellowship at Stanford. She received the Outstanding Research Award in Acute Pain at the Society of Pediatric Pain Medicine Annual Conference in 2016. Her interests include utilization of regional anesthesia and comprehensive multimodal analgesic protocols in the reduction of opioid consumption for acute pain in pediatric patients.

Clinical Focus


  • Pediatric Anesthesia
  • Pediatric Regional Anesthesia
  • Pediatric Acute Pain
  • Fetal Anesthesia
  • Simulation in Medical Education
  • Patient Safety
  • Quality Improvement

Academic Appointments


Honors & Awards


  • Outstanding Research Award in Acute Pain, Society of Pediatric Pain Medicine Annual Meeting (2016)
  • Patient-Oriented Research Poster Award in Anesthesiology & Critical Care Medicine, CHOP Research Poster Day (2016)

Boards, Advisory Committees, Professional Organizations


  • Co-Chair, LPCH Pediatric Anesthesia Safety Committe (2017 - Present)
  • Member, LPCH Care Improvement Committee (2018 - Present)
  • Member, Society of Pediatric Anesthesia - Simulation SIG (2016 - Present)
  • Member, Society of Pediatric Anesthesia - SPAIN Committee (2016 - Present)
  • Member, LPCH Pediatric Anesthesia Professional Practice Evaluation Committee (2017 - Present)
  • Member, Wake Up Safe (2018 - Present)

Professional Education


  • Medical Education: Yale School Of Medicine (2011) CT
  • Internship: California Pacific Medical Center Dept of Medicine (2012) CA
  • Fellowship: Childrens Hospital of Philadelphia Pediatric Pathology (2016) PA
  • Board Certification: American Board of Anesthesiology, Pediatric Anesthesia (2016)
  • Board Certification: American Board of Anesthesiology, Anesthesia (2016)
  • Residency: University of California San Francisco (2015) CA
  • Board Certification, Pediatric Anesthesiology (2016)
  • Board Certification, Anesthesiology (2016)
  • Fellowship, The Children's Hospital of Philadelphia, Pediatric Anesthesiology (2016)
  • Residency, University of California, San Francisco, Anesthesiology (2015)
  • Internship, California Pacific Medical Center, Internal Medicine (2012)
  • MD, Yale University School of Medicine (2011)

All Publications


  • Novel Utilization of Strand-Specific Reverse Transcription Polymerase Chain Reaction in Perioperative Clinical Decision Making for SARS-CoV-2 Polymerase Chain Reaction Positive Patients. Paediatric anaesthesia Jette, C. G., Wang, T., Wang, E., Man, J. Y., Mireles, S., Maass, B., Mathew, R., Pinsky, B. A., Claure, R., D'Souza, G. 2022

    Abstract

    In order to prevent in-hospital transmission and potential complications related to SARS-CoV-2 in the perioperative patient, most healthcare institutions require preoperative testing for SARS-CoV-2 prior to proceeding with elective surgery. The Centers for Disease Control and Prevention (CDC) recommends a time and symptom-based duration of isolation for the presumed infectious period. The guidance to avoid retesting of asymptomatic patients in the 90days following a positive reverse transcription polymerase chain reaction (RT-PCR) test is because of the possibility of detection of non-infectious viral shedding. When to reschedule asymptomatic patients who test RT-PCR positive for SARS-CoV-2 preoperatively is of considerable debate, both from the perspective of ensuring a patient's full preoperative fitness, as well as reducing the risk of viral transmission within the hospital. We describe the novel perioperative use of a strand-specific assay to detect minus strand ribonucleic acid (RNA) in a clinical decision-making algorithm to determine optimal timing of elective surgery after a patient tests RT-PCR positive for SARS-CoV-2. This is the first description in the literature of an attempt to further stratify patients who repeatedly test positive for SARS-CoV-2 into infectious versus non-infectious for perioperative planning.

    View details for DOI 10.1111/pan.14448

    View details for PubMedID 35338765

  • Pre-operative fasting times for clear liquids at a tertiary children's hospital; what can be improved? Anesthesia and pain medicine Schmidt, A. R., Fehr, J., Man, J., D'Souza, G., Wang, E., Claure, R., Mendoza, J. 2021

    Abstract

    Background: The goal of preoperative fasting is to prevent pulmonary aspiration during general anesthesia. Fasting times are often prolonged leading to patient discomfort and risk for adverse events. This retrospective quality improvement survey evaluated effective nil-per-os (NPO) times and causes for prolonged NPO times with the aim to suggest improvement strategies by a newly founded fasting task force.Methods: Data from all electronic anesthesia records from 2019 at our institution were reviewed for fasting times. Our NPO instructions follow American Society of Anesthesiology guidelines and are calculated based on the patient's arrival time (90 min before operating room [OR] time). Primary outcome was the effective NPO time for clear liquids, secondary outcomes were incidence of delays and the parental compliance with the NPO instructions. Data are presented as median (interquartile range).Results: In total 9,625 cases were included in the analysis. NPO time was documented in 72.1% with a median effective NPO time of 7:13 h (7:36). OR in room times were documented in 72.8%, 2,075 (29.5%; median time 0:10 h [0:21]) were earlier and 4,939 (70.5%; median time 0:29 h [0:54]) were later than scheduled. Parental NPO compliance showed a median deviation for clear liquid intake of 0:55 h (8:30).Conclusions: This study revealed that effective NPO times were longer than current ASA guidelines. Contributing causes include case delays and parental non-compliance to NPO instructions. Thus, task force recommendations include change NPO instruction calculations to scheduled OR time versus arrival time, and encourage parents to give their child clear liquids at the instructed time.

    View details for DOI 10.17085/apm.21025

    View details for PubMedID 34289299

  • Technique Utilizing a Modified Oral Ring-Adair-Elwyn Tube to Provide Continuous Oxygen and Sevoflurane Delivery During Nasotracheal Intubation in an Infant With a Difficult Airway: A Case Report. A&A practice Man, J. Y., Fiadjoe, J. E., Hsu, G. 2018; 10 (10): 254-257

    Abstract

    Managing the airway of an infant with Pierre Robin sequence (PRS) is particularly challenging for anesthesiologists. Patients with PRS have the triad of micrognathia, glossoptosis, and airway obstruction that potentially and frequently leads to difficulty with both ventilation and intubation. Thus continuous oxygenation and spontaneous ventilation during intubation are essential. We describe a new method to deliver continuous oxygen and volatile anesthetic during nasotracheal intubation in an infant with PRS.

    View details for DOI 10.1213/XAA.0000000000000677

    View details for PubMedID 29757793

  • A retrospective comparison of thoracic epidural infusion and multimodal analgesia protocol for pain management following the minimally invasive repair of pectus excavatum. Paediatric anaesthesia Man, J. Y., Gurnaney, H. G., Dubow, S. R., DiMaggio, T. J., Kroeplin, G. R., Adzick, N. S., Muhly, W. T. 2017; 27 (12): 1227-1234

    Abstract

    Pain management following minimally invasive repair of pectus excavatum is variable. We recently adopted a comprehensive multimodal analgesic protocol that standardizes perioperative analgesic management. We hypothesized that patients managed with this protocol would use more opioids postoperatively, have similar pain control, and shorter length of stay compared to patients managed with thoracic epidural infusion.We retrospectively compared opioid consumption, pain scores, and length of stay between a cohort of patients managed with our multimodal analgesic protocol and a cohort managed with a thoracic epidural infusion.This retrospective cohort comparison includes patients, 8 to 21 years of age, managed with either thoracic epidural infusion (n = 21) or multimodal analgesic protocol (n = 29) following minimally invasive repair of pectus excavatum from January 1, 2011 through September 15, 2015. The primary outcome, total daily opioid consumption in morphine equivalents, is presented as an average by postoperative day. Secondary outcomes included median daily pain score and length of stay.Patients were similar in age, weight, sex, and physical status. Patients managed with thoracic epidural infusion received less opioid (morphine equivalents-mg/kg) intraoperatively compared to multimodal analgesic protocol (difference of mean [95% confidence interval] 0.22 [0.16-0.28] P ≤ .01) but required more total opioid through postoperative day 3 (difference of mean [95% confidence interval] 1.2 [0.26-2.14] P = .01). We did not observe a difference in pain scores. Median length of stay was 1 day less in patients managed with multimodal analgesic protocol (difference of median [95% confidence interval] 1 [0.3-1.7] P = .003).Implementation of a standardized comprehensive multimodal analgesic protocol following minimally invasive repair of pectus excavatum resulted in equivalent analgesia with a modest reduction in length of stay when compared to thoracic epidural. We did not observe an opioid sparing effect in our thoracic epidural which may reflect technique variability.

    View details for DOI 10.1111/pan.13264

    View details for PubMedID 29063665

  • Technique Utilizing a Modified Oral Ring-Adair-Elwyn Tube to Provide Continuous Oxygen and Sevoflurane Delivery During Nasotracheal Intubation in an Infant With a Difficult Airway: A Case Report. A & A case reports Man, J. Y., Fiadjoe, J. E., Hsu, G. n. 2017

    Abstract

    Managing the airway of an infant with Pierre Robin sequence (PRS) is particularly challenging for anesthesiologists. Patients with PRS have the triad of micrognathia, glossoptosis, and airway obstruction that potentially and frequently leads to difficulty with both ventilation and intubation. Thus continuous oxygenation and spontaneous ventilation during intubation are essential. We describe a new method to deliver continuous oxygen and volatile anesthetic during nasotracheal intubation in an infant with PRS.

    View details for DOI 10.1213/XAA.0000000000000677

    View details for PubMedID 29210721

  • The role of CD8(+) T-cell replicative senescence in human aging IMMUNOLOGICAL REVIEWS Effros, R. B., Dagarag, M., Spaulding, C., Man, J. 2005; 205: 147-157

    Abstract

    The strict limit in proliferative potential of normal human somatic cells - a process known as replicative senescence - is highly relevant to the immune system, because clonal expansion is fundamental to adaptive immunity. CD8(+) T cells that undergo extensive rounds of antigen-driven proliferation in cell culture invariably reach the end stage of replicative senescence, characterized by irreversible cell-cycle arrest and a critically short telomere length. Cultures of senescent CD8(+) T cells also show resistance to apoptosis, permanent loss of CD28 expression, altered cytokine profiles, reduced ability to respond to stress, and various functional changes. Cells with similar characteristics accumulate during normal aging as well as in younger persons infected with human immunodeficiency virus, suggesting that the process of replicative senescence is not an artifact of cell culture but is also occurring in vivo. Interestingly, in elderly persons, the presence of high proportions of CD8(+) T cells with characteristics of replicative senescence is correlated with reduced antibody responses to vaccines as well as with osteoporotic fractures. CD8(+)CD28(-) T cells also accumulate in patients with certain types of cancer. The emerging picture is that senescent CD8(+) T cells may modulate both immune and non-immune functions, contributing not only to reduced anti-viral immunity but also to diverse age-related pathologies.

    View details for Web of Science ID 000228976300012

    View details for PubMedID 15882351